SAFEs are popular because they are supposed to reduce friction. That promise can hold for the base instrument, but it often starts breaking down when investors request side letters. A side letter is where a supposedly “simple” SAFE round can quietly turn into a layered governance and allocation problem.
This happens because the side letter is where investors negotiate rights that are not obvious from the headline SAFE terms alone: future participation rights, MFN mechanics, “Major Investor” treatment in a later equity round, periodic reporting, expense reimbursement, or board-observer access. None of those rights are automatically bad. They just stop the round from being simple in the way founders expected.
If you want the broader financing background first, read Startup Venture Financing Explained and SAFE Notes vs. Convertible Notes. This article assumes you already know what a SAFE is and want to understand where side letters create leverage, friction, or future dilution pressure.
In This Guide
- Why SAFE side letters change the round
- The main rights founders usually see
- Post-money SAFE traps founders underestimate
- Copy-and-paste starter side-letter language
- Founder checklist before signing
Why SAFE Side Letters Change the Round
Founders sometimes treat the SAFE itself as the entire deal and the side letter as a minor accommodation. That framing is dangerous. The SAFE sets the conversion economics. The side letter often sets the investor’s future leverage.
Once multiple SAFE investors have different side-letter rights, the company is no longer running a single instrument. It is running a baseline instrument plus a matrix of special rights that may affect notice obligations, future allocations, access to information, and the administrative burden of the next financing.
The Main SAFE Side-Letter Rights
1. MFN Rights
MFN rights are especially common in SAFE rounds because investors know the company may issue later SAFEs or bridge instruments on different caps, discounts, or side terms. The practical founder question is never just whether MFN exists. It is whether the company has drawn sensible exceptions and whether the election mechanics are clear enough to administer later.
2. Future Equity Participation / Pro Rata Rights
This is where post-money SAFE rounds can become more complicated than founders expected. A side letter may give the investor a right to buy additional shares in the next equity round, sometimes based on a negotiated amount and sometimes based on a true pro rata formula. When several SAFE investors have similar rights, the later financing can feel pre-allocated before the lead investor has even sized the round.
3. “Major Investor” Rights in the Next Equity Financing
Some side letters ask the company to ensure that, when the SAFE converts, the investor will count as a “Major Investor” under the later financing documents. That sounds narrow, but it can bring along future participation rights, information rights, and other governance-style privileges that were meant for a smaller subset of the cap table.
4. Information Rights
Quarterly updates or annual financial statements may be reasonable for a lead or strategically valuable investor. They are less attractive when the company has promised essentially the same package to a long tail of smaller SAFE holders. Founders should decide what reporting burden they are willing to live with before they distribute that right repeatedly.
5. Board Observer Rights
Observer rights in a SAFE side letter deserve the same caution they would get in a priced round. They are not just “extra transparency.” They affect board process, privilege judgments, confidentiality, and competitor risk. If observer rights are granted, the letter should be explicit about non-voting status, confidentiality, privilege carveouts, and the company’s right to exclude the observer from particularly sensitive sessions.
Post-Money SAFE Traps Founders Underestimate
- Assuming the SAFE cap tells the whole dilution story. Side-letter participation rights can change what the next round feels like in practice.
- Granting parallel side letters without a central tracker. The company later forgets who has MFN, who has pro rata, and who expected information rights.
- Using vague “Major Investor” language. If the later financing documents define that term differently than expected, the company may be stuck negotiating around a promise it made too casually.
- Ignoring operational cost. Small investors with governance-style rights create real workload for a private company.
- Forgetting that simple documents can still create complex cap-table outcomes.
Copy-and-Paste Starter Side-Letter Language
Important: this is simplified educational starter language only, meant to help founders understand structure and issue-spotting. It is not a complete or production-ready SAFE side letter.
[COMPANY NAME] [DATE] [INVESTOR NAME] Re: Side Letter to SAFE Financing In connection with Investor's purchase of one or more SAFEs issued by the Company, the Company and Investor agree as follows. Capitalized terms used but not defined here have the meanings given in the SAFE. 1. MFN Notice Right. If, before the SAFE terminates, the Company issues a later SAFE or convertible note with materially more favorable economic terms, the Company will notify Investor in writing within [X] days after such issuance. Investor may elect, within [Y] days after notice, to amend Investor's SAFE to reflect those more favorable economic terms, except for excluded issuances such as employee equity, commercial financing arrangements, and strategic business transactions. 2. Future Equity Participation Right. Before the closing of the next equity financing, Investor may purchase up to [insert negotiated amount or formula] of the securities offered in that financing on the same price and terms offered to similarly situated investors, subject to legal-compliance limitations and Investor remaining an accredited investor. 3. Information Rights. Until termination of the SAFE, the Company will provide Investor with [annual unaudited financial statements] and [quarterly business updates], subject to customary confidentiality obligations and privilege / trade-secret carveouts. 4. Board Observer Right. The Company may invite one representative of Investor to attend board meetings in a non-voting observer capacity, provided the Company may exclude the observer from any discussion or withhold any materials as reasonably necessary to protect attorney-client privilege, competitively sensitive information, or trade secrets. 5. Expenses. The Company will / will not reimburse reasonable documented legal expenses of Investor in an amount not to exceed [$X]. 6. Termination. The rights in this letter terminate automatically upon the earliest of [the SAFE's termination], [closing of the next equity financing], or [a written agreement of the parties], except that confidentiality obligations survive as stated here.
Founder Checklist Before Signing
- What later instruments are excluded from MFN treatment?
- Does the side letter create a fixed right, a formula right, or just a notice right?
- How will the company track these rights across multiple SAFE investors?
- Will the later lead investor view the side-letter package as manageable or annoying?
- Has anyone modeled how these rights affect the next round’s practical allocation flexibility?
Official Resources and Forms
- SEC exempt-offerings overview
- SEC Rule 506 / private-placement overview
- Investor.gov accredited-investor glossary
Related Montague Law Guides
- Startup Venture Financing Explained
- SAFE Notes vs. Convertible Notes
- Startup Legal Mistakes Checklist
This article is for general educational purposes only and is not legal advice. SAFE side letters should be evaluated together with the SAFE form, the company’s financing strategy, the expected investor stack, and the later-round allocation plan.
